FMP
Jun 5, 2024 4:59 PM - Davit Kirakosyan
Dollar Tree (NASDAQ:DLTR) reported Q1 earnings that met expectations and revised its outlook for the full fiscal year 2024.
For Q1, the discount retailer reported earnings per share (EPS) of $1.43, aligning with the analyst forecast of $1.43. Revenue for the quarter was $7.63 billion, slightly below the expected $7.65 billion.
Comparable sales across the enterprise grew by 1%, compared to 4.8% year-over-year, but fell short of the anticipated 2.33%. The gross profit margin was 30.8%, up from 30.5% the previous year, meeting the estimate of 30.8%.
For fiscal year 2025, the company forecasts an EPS range of $6.50 to $7.00, down from the previous range of $6.70 to $7.30, and below the consensus estimate of $6.89 at the midpoint. Expected revenue for the year is between $31 billion and $32 billion, compared to the projected $31.4 billion.
Additionally, the company announced a strategic review of its Family Dollar business, exploring options such as a potential sale or spinoff, with JPMorgan Chase leading the review.
This news, initially reported by the Wall Street Journal, led to a 5% increase in shares in pre-market today, but currently they are down more than 4% intra-day.
Oct 31, 2023 8:03 AM - Parth Sanghvi
Free cash flow to the firm (FCFF) and free cash flow to equity (FCFE) are two of the most important metrics used in financial modeling. Both metrics measure the amount of cash that is available to a company's shareholders and creditors, but there is a key difference between the two. FCFF measures...
Nov 25, 2023 6:39 AM - Parth Sanghvi
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...
Dec 23, 2023 2:19 AM - Parth Sanghvi
Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...